Evidence map›Paper›PMID 35928127›Full record

ArticleFrontiers in neurology2022

Does Executive Function Influence Walking in Acutely Hospitalized Patients With Advanced Parkinson's Disease: A Quantitative Analysis.

Johanna Geritz, Julius Welzel, Clint Hansen, Corina Maetzler, Markus A Hobert, Morad Elshehabi, Alexandra Sobczak, Jennifer Kudelka, Christopher Stiel, Johanne Hieke and 3 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in neurology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Johanna GeritzDepartment of Neurology, University Hospital Schleswig-Holstein, Kiel, Germany.
Julius WelzelDepartment of Neurology, University Hospital Schleswig-Holstein, Kiel, Germany.
Clint HansenDepartment of Neurology, University Hospital Schleswig-Holstein, Kiel, Germany.
Corina MaetzlerDepartment of Neurology, University Hospital Schleswig-Holstein, Kiel, Germany.
Markus A HobertDepartment of Neurology, University Hospital Schleswig-Holstein, Kiel, Germany.
Morad ElshehabiDepartment of Neurology, University Hospital Schleswig-Holstein, Kiel, Germany.
Alexandra SobczakDepartment of Psychology and Center of Brain, Behavior and Metabolism (CBBM), University of Lübeck, Lübeck, Germany.
Jennifer KudelkaDepartment of Neurology, University Hospital Schleswig-Holstein, Kiel, Germany.
Christopher StielDepartment of Neurology, University Hospital Schleswig-Holstein, Kiel, Germany.
Johanne HiekeDepartment of Neurology, University Hospital Schleswig-Holstein, Kiel, Germany.
Annekathrin AlpesDepartment of Neurology, University Hospital Schleswig-Holstein, Kiel, Germany.
Nico BunzeckDepartment of Psychology and Center of Brain, Behavior and Metabolism (CBBM), University of Lübeck, Lübeck, Germany.
Walter MaetzlerDepartment of Neurology, University Hospital Schleswig-Holstein, Kiel, Germany.
University Hospital Schleswig-Holstein · DEUniversity of Lübeck · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: It is well-known that, in Parkinson's disease (PD), executive function (EF) and motor deficits lead to reduced walking performance. As previous studies investigated mainly patients during the compensated phases of the disease, the aim of this study was to investigate the above associations in acutely hospitalized patients with PD. Methods: A total of seventy-four acutely hospitalized patients with PD were assessed with the delta Trail Making Test (ΔTMT, TMT-B minus TMT-A) and the Movement Disorder Society-revised version of the motor part of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS III). Walking performance was assessed with wearable sensors under single (ST; fast and normal pace) and dual-task (DT; walking and checking boxes as the motor secondary task and walking and subtracting seven consecutively from a given three-digit number as the cognitive secondary task) conditions over 20 m. Multiple linear regression and Bayes factor BF Results: Under ST, significant negative effects of the use of a walking aid and MDS-UPDRS III on gait speed and at a fast pace on the number of steps were observed. Moreover, depending on the pace, the use of a walking aid, age, and gender affected step time variability. Under walking-cognitive DT, a resolved variance of 23% was observed in the overall model for step time variability DTC, driven mainly by age (β = 0.26, Discussion: The results of this study suggest that, in acutely hospitalized patients with PD, reduced walking performance is mainly explained by the use of a walking aid, motor symptoms, age, and gender, and EF deficits surprisingly do not seem to play a significant role. However, these patients with PD should avoid walking-cognitive DT situations, as under this condition, especially step time variability, a parameter associated with the risk of falling in PD worsens.

Indexed as

ageddual taskexecutive functionsParkinson's diseasestraight walkingwearable sensors

Identifiers

PMID35928127
PMCPMC9344922
OpenAlexW4285795416

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.